Zika virus envelope protein quaternary epitope (ZIKV E quaternary epitope)

The Zika virus envelope (E) protein quaternary epitope is a complex antigenic site formed by the specific spatial arrangement of E protein subunits on the surface of mature Zika virions or virus-like particles (VLPs). Unlike simple linear epitopes, these quaternary sites often span across adjacent E protein dimers, such as the Envelope Dimer Epitope (EDE), making them highly specific to the assembled viral architecture (Hasan et al., 2017, Nature). These epitopes are the primary targets for the most potent neutralizing antibodies, which inhibit infection by blocking viral attachment to host receptors or preventing the pH-triggered membrane fusion process (Sapparapu et al., 2016, Nature). In the context of disease, the E protein is essential for the virus's ability to infect host cells, including neural progenitor cells, leading to severe outcomes like microcephaly and Congenital Zika Syndrome. Therapeutic strategies focusing on these epitopes aim to provide passive immunity through monoclonal antibodies like ZIKV-117 or to elicit a robust protective response through structure-based vaccine design (Dejnirattisai et al., 2016, Nature Immunology). A significant challenge in targeting these epitopes is the risk of antibody-dependent enhancement (ADE), where cross-reactive but non-neutralizing antibodies can facilitate viral entry into Fc-receptor-bearing cells (Stettler et al., 2016, Science). This phenomenon is particularly concerning due to the structural similarity between Zika and Dengue virus envelope proteins. Consequently, drug and vaccine development must prioritize epitopes that elicit strongly neutralizing responses while minimizing the potential for ADE.

Other names

Envelope dimer epitopeEDEZIKV E-dimer epitopeQuaternary structure epitopeVirion-associated epitopeZIKV E-protein dimer

Neutralization of viral particles by blocking receptor binding or preventing the conformational changes necessary for endosomal membrane fusion.